Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Continuous expression of all four factors in normal mice, however, often induces teratomas17–19 or is fatal within days16, ostensibly due to tissue dysplasia18.”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [18]
In the citing paper
“Teratoma formation has been observed in partially reprogrammed animals, particularly when c-Myc is used in the partial rejuvenation cocktail (Abad et al., 2013; Ocampo et al., 2016; Ohnishi et al., 2014; Senís et al., 2018)”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Abad et al., 2013
In the citing paper
“cellular reprogramming to pluripotency, although associated with tumor development (e.g., teratoma formation), can be achieved in vivo in mice by the forced expression of the Yamanaka factors”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“Although previous studies have indicated that expression of the Yamanaka factors in vivo can lead to cancer development or teratoma formation (Abad et al., 2013;Ohnishi et al., 2014), here, we demonstrate that tumor formation can be avoided by short-term induction of OSKM.”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“The Yamanaka factors possess oncogenic properties, which can lead to teratoma formation when persistently overexpressed in vivo (Abad et al., 2013; Ohnishi et al., 2014).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Abad et al., 2013
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Embryonic stem cell potency fluctuates with endogenous retrovirus activity
Macfarlan, T. S., Gifford, W. D., Driscoll, S., Lettieri, K., Rowe, H. M., Bonanomi, D., Firth, A., Singer, O., Trono, D., & Pfaff, S. L. (2012) · Nature · doi:10.1038/nature11244 · Cited by 981
Hanna, J., Cheng, A. W., Saha, K., Kim, J., Lengner, C. J., Soldner, F., Cassady, J. P., Muffat, J., Carey, B. W., & Jaenisch, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004584107 · Cited by 847
Cited by
Items 201–300 of 617
Martín‐López, M., Maeso‐Alonso, L., Fuertes-Álvarez, S., Balboa, D., Rodríguez-Cortez, V., Weltner, J., Diez-Prieto, I., Davis, A. J., Wu, Y., Otonkoski, T., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.432 · Cited by 26
Çalbıyık, M., & Zehir, S. (2023) · Medicine · doi:10.1097/md.0000000000034208 · Cited by 26
Natural killer cells act as an extrinsic barrier for in vivo reprogramming
Melendez, E., Chondronasiou, D., Mosteiro, L., de Villarreal, J. M., Fernández‐Alfara, M., Lynch, C. J., Grimm, D., Real, F. X., Alcamí, J., Climent, N., et al. (2022) · Development · doi:10.1242/dev.200361 · Cited by 26
Self-citationProgress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease
Fang, Y., Wang, S. P. H., Chang, H., Yang, P.-J., Liu, P., & Liu, Y.-W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010102 · Cited by 26
Zhu, S., Wang, J., Zellmer, L., Xu, N., Liu, M., Hu, Y., Ma, H., Deng, F., Yang, W., & Liao, D. J. (2022) · Journal of Cancer · doi:10.7150/jca.72628 · Cited by 25
Morel, G., Chiavellini, P., Canatelli-Mallat, M., Lehmann, M., & Goya, R. G. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320966 · Cited by 25
Tumoral reprogramming: Plasticity takes a walk on the wild side
Campos‐Sánchez, E., & Cobaleda, C. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.003 · Cited by 25
The Impact of Oxygen Availability and Multilineage Communication on Organoid Maturation
Wörsdörfer, P., & Ergün, S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8195 · Cited by 24
Kim, J., Hwang, Y., Kim, S., Chang, Y., Kim, Y.-K., Kwon, Y., & Kim, J. (2023) · Aging Cell · doi:10.1111/acel.13825 · Cited by 24
No Time to Age: Uncoupling Aging from Chronological Time
Larocca, D., Lee, J., West, M. D., Labat, I., & Sternberg, H. (2021) · Genes · doi:10.3390/genes12050611 · Cited by 24
Renal stem cell reprogramming: Prospects in regenerative medicine
Morales, E. E., & Wingert, R. A. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i4.458 · Cited by 23
Okeyo, K. O., Kurosawa, O., Yamazaki, S., Oana, H., Kotera, H., Nakauchi, H., & Washizu, M. (2015) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0038 · Cited by 23
Elixir of Life: Thwarting Aging With Regenerative Reprogramming
Beyret, E., Martínez‐Redondo, P., Platero-Luengo, A., & Belmonte, J. C. I. (2018) · Circulation Research · doi:10.1161/circresaha.117.311866 · Cited by 23
Aging and rejuvenation - a modular epigenome model
Chiavellini, P., Canatelli-Mallat, M., Lehmann, M., Gallardo, M. D., Hereñú, C. B., Cordeiro, J. L., Clement, J., & Goya, R. G. (2021) · Aging · doi:10.18632/aging.202712 · Cited by 23
The foundational framework of tumors: Gametogenesis, p53, and cancer
Liu, C., Moten, A., Ma, Z., & Lin, H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.018 · Cited by 24
Tang, Y., & Cheng, L. (2017) · Protein & Cell · doi:10.1007/s13238-017-0373-y · Cited by 22
“, 2013), although long-term induction of the factors in vivo still can generate induced pluripotent stem cells in situ (Abad et al., 2013).”
The evolution of cancer and ageing: a history of constraint
de Magalhães, J. P. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00861-4 · Cited by 22
The intricate nature of senescence in development and cell plasticity
Gal, H., Majewska, J., & Krizhanovsky, V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.004 · Cited by 22
ImAge quantitates aging and rejuvenation
Alvarez-Kuglen, M., Ninomiya, K., Qin, H., Rodriguez, D., Fiengo, L., Farhy, C., Hsu, W.-M., Kirk, B. D., Havas, A. P., Kaufman, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00685-1 · Cited by 23
Self-citationAging and the Krüppel-like factors.
Hsieh, P. N., Sweet, D. R., Fan, L., & Jain, M. K. (2017) · PubMed · Cited by 23
The crosstalk between cellular reprogramming and senescence in aging and regeneration
Chiche, A., Chen, C., & Li, H. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111005 · Cited by 22
Salazar‐Roa, M., Trakala, M., Álvarez‐Fernández, M., Valdés‐Mora, F., Zhong, C., Muñoz, J., Yu, Y., Peters, T. J., Graña‐Castro, O., Serrano, R., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104324 · Cited by 22
Self-citationCombining stem cell rejuvenation and senescence targeting to synergistically extend lifespan
Kaur, P., Otgonbaatar, A., Ramamoorthy, A., Chua, E. H. Z., Harmston, N., Gruber, J., & Tolwinski, N. S. (2022) · Aging · doi:10.18632/aging.204347 · Cited by 22
Rejuvenation by Partial Reprogramming of the Epigenome
Mendelsohn, A. R., Larrick, J. W., & Lei, J. L. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1958 · Cited by 22
Encabo-Berzosa, M. D. M., Gimeno, M., Luján, L., Sancho‐Albero, M., Gómez, L., Sebastián, V., Quintanilla, M., Arruebo, M., Santamaría, J., & Martín‐Duque, P. (2016) · RSC Advances · doi:10.1039/c6ra10058a · Cited by 21
Inhibition of neural stem cell aging through the transient induction of reprogramming factors
Han, M. J., Lee, W. J., Choi, J., Hong, Y. J., Uhm, S. J., Choi, Y., & Tae, J. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24967 · Cited by 21
Li, C., Hsu, T., Chang, Y., Chan, M., Lu, P., & Hsiao, M. (2021) · Biomedicines · doi:10.3390/biomedicines9091265 · Cited by 21
Aryl hydrocarbon receptor blocks aging-induced senescence in the liver and fibroblast cells
Nacarino-Palma, A., Rico-Leo, E. M., Campisi, J., Ramanathan, A., González-Rico, F. J., Rejano-Gordillo, C. M., Ordiales-Talavero, A., Merino, J. M., & Fernández‐Salguero, P. M. (2022) · Aging · doi:10.18632/aging.204103 · Cited by 21
Reversal of ageing- and injury-induced vision loss by Tet-dependent epigenetic reprogramming
Lu, Y., Krishnan, A., Brommer, B., Tian, X., Meer, M., Vera, D. L., Wang, C., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2019) · doi:10.1101/710210 · Cited by 20
Carcinogenesis resistance in the longest‐lived rodent, the naked mole‐rat
Yamamura, Y., Kawamura, Y., Oka, K., & Miura, K. (2022) · Cancer Science · doi:10.1111/cas.15570 · Cited by 20
The Role of SOX Transcription Factors in Ageing and Age-Related Diseases
Stevanović, M. J., Lazic, A., Schwirtlich, M., & Ninković, D. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010851 · Cited by 20
Unveiling the Role of Senescence-Induced Cellular Plasticity
Taguchi, J., & Yamada, Y. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.02.001 · Cited by 20
Matsumoto, Y., & Miglietta, M. P. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab136 · Cited by 20
Iacovides, D. C., Rizki, G., Lapathitis, G., & Strati, K. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0357-5 · Cited by 20
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
Cazin, C., Chiche, A., & Li, H. (2017) · Journal of Visualized Experiments · doi:10.3791/56201 · Cited by 20
Wang, Y., Lü, T., Sun, G., Zheng, Y., Yang, S., Zhang, H., Hao, S., Liu, Y., Ma, S., Zhang, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13411-y · Cited by 20
Reprogramming and transdifferentiation - two key processes for regenerative medicine
Hybiak, J., Jankowska, K., Machaj, F., Rosik, J., Broniarek, I., Żyluk, A., Hilderman, G. C., Małecki, A., Łoś, M., & Urasińska, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173202 · Cited by 20
A cellular identity crisis? Plasticity changes during aging and rejuvenation
Gorelov, R. A., & Hochedlinger, K. (2024) · Genes & Development · doi:10.1101/gad.351728.124 · Cited by 19
Le, N., Awad, S., Palazzo, I., Hoang, T. V., & Blackshaw, S. (2025) · eLife · doi:10.7554/elife.106450 · Cited by 21
Reprogramming of human somatic cells by bacteria
Ito, N., & Ohta, K. (2015) · Development Growth & Differentiation · doi:10.1111/dgd.12209 · Cited by 19
Winkler, S., Hempel, M., Brückner, S., Mallek, F., Weise, A., Liehr, T., Tautenhahn, H., Bartels, M., & Christ, B. (2015) · Acta Physiologica · doi:10.1111/apha.12560 · Cited by 19
Stem cell state and the epithelial-to-mesenchymal transition: Implications for cancer therapy
Donnenberg, V. S., & Donnenberg, A. D. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.486 · Cited by 19
Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies
Adami, R., & Bottai, D. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09910-6 · Cited by 19
Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation
Lehmann, M., Canatelli-Mallat, M., Chiavellini, P., Cónsole, G. M., Gallardo, M. D., & Goya, R. G. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190902154511 · Cited by 19
Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines
de Jesus, B. B., Neves, B. M., Ferreira, M. M., & Pereira, S. N. (2020) · Cancers · doi:10.3390/cancers12123581 · Cited by 19
Somatic Reprogramming—Above and Beyond Pluripotency
Meir, Y. J., & Li, G. (2021) · Cells · doi:10.3390/cells10112888 · Cited by 20
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaître, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 20
Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression
Rejano-Gordillo, C. M., Ordiales-Talavero, A., Nacarino-Palma, A., Merino, J. M., González-Rico, F. J., & Fernández‐Salguero, P. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.884004 · Cited by 19
Sing, T. L., Brar, G. A., & Ünal, E. (2022) · Annual Review of Genetics · doi:10.1146/annurev-genet-080320-025104 · Cited by 19
Quantitative evaluation method for differentiation of C2C12 myoblasts by ultrasonic microscopy
Takanashi, K., Washiya, M., Ota, K., Yoshida, S., Hozumi, N., & Kobayashi, K. (2017) · Japanese Journal of Applied Physics · doi:10.7567/jjap.56.07jf11 · Cited by 19
Centenarians Overexpress Pluripotency-Related Genes
Inglés, M., Mas‐Bargues, C., Berna‐Erro, A., Matheu, A., Sanchís, P., Avellana, J. A., Borrás, C., & Viña, J. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly168 · Cited by 19
Göbel, C., Goetzke, R., Eggermann, T., & Wagner, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-30069-6 · Cited by 19
Fütterer, A., Gutiérrez, A., Pons, T., de Celis, J., Gutiérrez, J., Plaza, V. D., & Martínez‐A, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03906-2 · Cited by 19
Rajabian, N., Choudhury, D., Ikhapoh, I. A., Saha, S., Kalyankar, A. S., Mehrotra, P., Shahini, A., Breed, K., & Andreadis, S. T. (2023) · Aging Cell · doi:10.1111/acel.13764 · Cited by 18
Yavarpour‐Bali, H., Ghasemi‐Kasman, M., & Shojaei, A. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109820 · Cited by 18
How can aging be reversed? Exploring rejuvenation from a damage‐based perspective
Zhang, B., & Gladyshev, V. N. (2020) · Advanced Genetics · doi:10.1002/ggn2.10025 · Cited by 18
Kisby, T., de Lázaro, I., Fisch, S., Cartwright, E. J., Cossu, G., & Kostarelos, K. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000141 · Cited by 18
Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care
Tu, S., Guo, C. C., Chow, D. S., & Zacharias, N. M. (2022) · Cancers · doi:10.3390/cancers14061548 · Cited by 18
The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling
Plana-Carmona, M., Stik, G., Bulteau, R., Segura-Morales, C., Alcázar, N., Wyatt, C. D. R., Klonizakis, A., de Andrés-Aguayo, L., Gasnier, M., Tian, T. V., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.009 · Cited by 18
Self-citationHess, S., Kendall, T. J., Peña, M. T., Yamane, K., Soong, D. Y. H., Adams, L. B., Truman, R. W., & Rambukkana, A. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100820 · Cited by 18
A NEW VIEW OF GENETIC MUTATIONS
Picimbon, J. (2017) · Australasian Medical Journal · doi:10.21767/amj.2017.3096 · Cited by 18
Tamanini, S., Comi, G. P., & Corti, S. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0888-0 · Cited by 18
Mitochondrial dynamics and metabolism in induced pluripotency
Prieto, J., Ponsoda, X., Belmonte, J. C. I., & Torres, J. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110870 · Cited by 18
Flitsch, L. J., & Brüstle, O. (2019) · F1000Research · doi:10.12688/f1000research.18926.1 · Cited by 18
T‐Zellplastizität bei entzündlichen Hauterkrankungen – die Guten, die Schlechten und die Chamäleons
Gatzka, M., & Scharffetter‐Kochanek, K. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12677 · Cited by 17
Strati, K. (2017) · Viruses · doi:10.3390/v9080221 · Cited by 17
Ghasemi‐Kasman, M., Baharvand, H., & Javan, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.094 · Cited by 17
Sogabe, Y., Seno, H., Yamamoto, T., & Yamada, Y. (2018) · Cancer Science · doi:10.1111/cas.13731 · Cited by 17
Regeneration, morphogenesis and self-organization
Goldman, D. J. (2014) · Development · doi:10.1242/dev.107839 · Cited by 17
The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse
Woltjen, K., Kim, S., & Nagy, A. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_274 · Cited by 17
Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan
Matteini, F., Montserrat‐Vazquez, S., & Florian, M. C. (2024) · FEBS Letters · doi:10.1002/1873-3468.14865 · Cited by 16
Zwi‐Dantsis, L., Jayarajan, V., Church, G. M., Kamm, R. D., de Magalhães, J. P., & Moeendarbary, E. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500217 · Cited by 16
Chromatin Regulation in Development: Current Understanding and Approaches
Zheng, Z., Sam, T. W., Zeng, Y., Chu, J. J. H., & Loh, Y. (2021) · Stem Cells International · doi:10.1155/2021/8817581 · Cited by 16
Shyu, Y., Liao, P.-C., Huang, T., Yang, C., Lu, M., Huang, S., Lin, X., Liou, C., Kao, Y.-J., Lu, C.-H., et al. (2022) · Advanced Science · doi:10.1002/advs.202201409 · Cited by 16
Regeneration through Reprogramming Adult Cell Identity in Vivo
Smith, D. K., & Zhang, C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.025 · Cited by 16
Advances in individualized and regenerative medicine
Blum, H. E. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2013.12.001 · Cited by 16
Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins
Vilas, J. M., Ferreirós, A., Carneiro, C., Morey, L., Silva‐Álvarez, S. D., Fernandes, T., Abad, M., Croce, L. D., García‐Caballero, T., Serrano, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2996 · Cited by 16
Self-citationThe Role of Krüppel-like Factors in Pancreatic Physiology and Pathophysiology
Giarrizzo, M., LaComb, J. F., & Bialkowska, A. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108589 · Cited by 15
Antón‐Fernández, A., de Alegría, Á. R., Mariscal-Casero, A., Roldán-Lázaro, M., Peinado-Cahuchola, R., Ávila, J., & Hernández, F. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102743 · Cited by 15
Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes
Menéndez, J. A., Alarcón, T., Corominas-Faja, B., Cuyàs, E., López‐Bonet, E., Martín, Á. G., & Vellón, L. (2014) · Cell Cycle · doi:10.4161/cc.27770 · Cited by 15
Matos, J. L., & Bergmann, D. C. (2014) · F1000Prime Reports · doi:10.12703/p6-53 · Cited by 15
Ha, J., Kim, B. S., Min, B., Nam, J., Lee, J.-G., Lee, M., Yoon, B.-H., Choi, Y. H., Im, I., Park, J. S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk1239 · Cited by 15
Differentiated Type II Pneumocytes Can Be Reprogrammed by Ectopic Sox2 Expression
Ochieng, J. K., Schilders, K. A. A., Kool, H. M., Kempen, M. B., Munck, A. B., Grosveld, F. G., Wijnen, R. M. H., Tibboel, D., & Rottier, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107248 · Cited by 15
Stem cells in regenerative medicine – from laboratory to clinical application – the eye
Dąbrowska, A. M., & Skopiński, P. (2017) · Central European Journal of Immunology · doi:10.5114/ceji.2017.69360 · Cited by 15
Mechanisms of cellular rejuvenation
Denoth‐Lippuner, A., & Jessberger, S. (2019) · FEBS Letters · doi:10.1002/1873-3468.13483 · Cited by 15
Utf1 contributes to intergenerational epigenetic inheritance of pluripotency
Bao, Q., Morshedi, A., Wang, F., Sharma, B., Pervushin, K. V., Yu, W., & Dröge, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-14426-5 · Cited by 14
Towards a Novel Frontier in the Use of Epigenetic Clocks in Epidemiology
Martínez‐Magaña, J. J., Hurtado-Soriano, J., Rivero-Segura, N. A., Montalvo‐Ortiz, J. L., Garcia-delaTorre, P., Becerril-Rojas, K., & Gómez-Verján, J. C. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103033 · Cited by 14
Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis
Lin, H., Wang, X., Chung, M., Cai, S., & Pan, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06060-3 · Cited by 14
Induced pluripotent stem cell technology for dissecting the cancer epigenome
Semi, K., & Yamada, Y. (2015) · Cancer Science · doi:10.1111/cas.12758 · Cited by 14
Lemaître, J.-M. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19820 · Cited by 14
p53: The Barrier or Guardian for Cell Dedifferentiation?
Pan, Y., Cai, S., Fu, X., & Andong, Z. (2014) · BioScience · doi:10.1093/biosci/biu133 · Cited by 14
Kato, N., Kamataki, A., & Kurotaki, H. (2020) · Modern Pathology · doi:10.1038/s41379-020-00668-8 · Cited by 14
Dane, D. M., Cao, K. N., Zhang, Y., Kernstine, K. H., Gazdhar, A., Geiser, T., & Hsia, C. C. W. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00205.2020 · Cited by 14
The Potential of iPSCs for the Treatment of Premature Aging Disorders
Compagnucci, C., & Bertini, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112350 · Cited by 14
Bone marrow-derived mesenchymal stromal cell: what next?
Borges, F. T., Convento, M. B., & Schor, N. (2018) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s147804 · Cited by 14
Research on induced pluripotent stem cells and the application in ocular tissues.
Guo, X., & Chen, J. (2015) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2015.04.31 · Cited by 15
Kriukov, D., Khrameeva, E. E., Gladyshev, V. N., Dmitriev, S. E., & Tyshkovskiy, A. (2022) · doi:10.1101/2022.12.12.520058 · Cited by 13
“To compare the rejuvenating trajectories of human and mouse cells subjected to OSKM treatment, we aggregated normalized tAge values across the datasets for each species and applied a moving average smoothing approach (Fig.”
BackgroundInfluentialChoi, H. W., Kim, J. S., Hong, Y. J., Song, H., Seo, H. G., & Tae, J. (2015) · Scientific Reports · doi:10.1038/srep13559 · Cited by 13
Regenerative Models for the Integration and Regeneration of Head Skeletal Tissues
Vieira, W. A., & McCusker, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123752 · Cited by 13
Transcriptomic reprogramming for neuronal age reversal
Pleşa, A. M., Shadpour, M., Boyden, E. S., & Church, G. M. (2023) · Human Genetics · doi:10.1007/s00439-023-02529-1 · Cited by 13
Metadata
- Authors
- Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., Manzanares, M., Ortega, S., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Corresponding author
- Serrano, Manuel
- Venue
- Nature
- Published
- 2013-09-11
- Volume
- 502
- Issue
- 7471
- Pages
- 340-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051454588
- Cited by
- 547
- References
- 46
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 41 · 2023: 46 · 2022: 51 · 2021: 46 · 2020: 47 · 2019: 35 · 2018: 38 · 2017: 47 · 2016: 26 · 2015: 38 · 2014: 54 · 2013: 11
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- CEU Repositorio Institucional (Fundación Universitaria San Pablo CEU) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- in vivo reprogramming, induced pluripotent stem cells, teratoma, totipotency, Yamanaka factors, Oct4, SOX2, KLF4, c-Myc, Nanog, trophectoderm, embryonic stem cells, regenerative medicine
- MeSH terms
- Kruppel-Like Factor 4, Animals, Blood Cells, Cell Separation, Cells, Cultured, Ectoderm, Female, Fibroblasts, Intestines, Kidney, Male, Mice, Inbred C57BL, Organ Specificity, Pancreas, Stomach, Teratoma, Trophoblasts, Proto-Oncogene Proteins c-myc, Gene Expression Profiling, Totipotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, Embryonic Stem Cells, Cell Dedifferentiation, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells, Embryoid Bodies, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.